KALA BIO, Inc. (KALA)
NASDAQ: KALA · Real-Time Price · USD
6.99
+0.66 (10.43%)
Dec 26, 2024, 2:26 PM EST - Market open
KALA BIO Employees
KALA BIO had 43 employees as of December 31, 2023. The number of employees increased by 9 or 26.47% compared to the previous year.
Employees
43
Change (1Y)
9
Growth (1Y)
26.47%
Revenue / Employee
n/a
Profits / Employee
-$906,116
Market Cap
32.22M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
IRIDEX | 111 |
IGC Pharma | 67 |
NKGen Biotech | 63 |
Calidi Biotherapeutics | 41 |
Sol-Gel Technologies | 36 |
Daré Bioscience | 26 |
ProMIS Neurosciences | 7 |
Intensity Therapeutics | 7 |
KALA News
- 4 weeks ago - KALA BIO to Present at Piper Sandler 36th Annual Healthcare Conference - GlobeNewsWire
- 7 months ago - KALA BIO to Present at Jefferies Global Healthcare Conference - GlobeNewsWire
- 8 months ago - KALA BIO Reports First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 9 months ago - KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update - GlobeNewsWire
- 10 months ago - KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference - GlobeNewsWire
- 1 year ago - KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 1 year ago - KALA BIO Reports Third Quarter 2023 Financial Results and Provides Corporate Update - GlobeNewsWire
- 1 year ago - KALA BIO to Present at H.C. Wainwright 25th Annual Global Investment Conference - GlobeNewsWire